579 related articles for article (PubMed ID: 12566656)
41. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?
Grzegorzewska AE
Pol Arch Med Wewn; 2009 Apr; 119(4):242-7. PubMed ID: 19413184
[TBL] [Abstract][Full Text] [Related]
42. Peritoneal Membrane Preservation.
Bajo MA; Del Peso G; Teitelbaum I
Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
[TBL] [Abstract][Full Text] [Related]
43. Peritoneal defense mechanisms--the effects of new peritoneal dialysis solutions.
Kazancioglu R
Perit Dial Int; 2009 Feb; 29 Suppl 2():S198-201. PubMed ID: 19270217
[TBL] [Abstract][Full Text] [Related]
44. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
45. Impact of glucose in peritoneal dialysis: saint or sinner?
Sitter T; Sauter M
Perit Dial Int; 2005; 25(5):415-25. PubMed ID: 16178471
[TBL] [Abstract][Full Text] [Related]
46. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
[TBL] [Abstract][Full Text] [Related]
47. Peritoneal exposure model in the rat as a tool to unravel bio(in)compatibility of PDF.
Fabbrini P; Zareie M; Ter Wee PM; Keuning ED; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii8-11. PubMed ID: 16825266
[TBL] [Abstract][Full Text] [Related]
48. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
[TBL] [Abstract][Full Text] [Related]
49. Clinical effects of biocompatible dialysis fluids.
Feriani M; Cancarini G; Garosi G; La Milia V
J Nephrol; 2013; 26 Suppl 21():76-82. PubMed ID: 24307440
[No Abstract] [Full Text] [Related]
50. Pathogenesis of peritoneal sclerosis.
Pollock C
Int J Artif Organs; 2005 Feb; 28(2):90-6. PubMed ID: 15770596
[TBL] [Abstract][Full Text] [Related]
51. Biocompatibility studies with bicarbonate-based solutions.
Pedersen FB
Adv Perit Dial; 1994; 10():245-50. PubMed ID: 7999838
[TBL] [Abstract][Full Text] [Related]
52. The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum?
Nessim SJ; Perl J; Bargman JM
Kidney Int; 2010 Jul; 78(1):23-8. PubMed ID: 20336052
[TBL] [Abstract][Full Text] [Related]
53. Multidirectional approach to study peritoneal dialysis fluid biocompatibility in a chronic peritoneal dialysis model in the rat.
Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Pawlaczyk K; Kuzlan-Pawlaczyk M; Filas V; Breborowicz A; Oreopoulos DG
Nephrol Dial Transplant; 2001 Mar; 16(3):655-6. PubMed ID: 11239060
[TBL] [Abstract][Full Text] [Related]
54. The John F. Maher Recipient Lecture 2004: Rage in the peritoneum.
De Vriese AS
Perit Dial Int; 2005; 25(1):8-11. PubMed ID: 15770917
[TBL] [Abstract][Full Text] [Related]
55. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
56. Strategy for preventing peritoneal dialysis failure.
Cancarini G
Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
[No Abstract] [Full Text] [Related]
57. Clinical indices of in vivo biocompatibility: the role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients.
Mackenzie R; Holmes CJ; Jones S; Williams JD; Topley N
Kidney Int Suppl; 2003 Dec; (88):S84-93. PubMed ID: 14870881
[TBL] [Abstract][Full Text] [Related]
58. Effects of bicarbonate/lactate dialysis solution on the inflammatory response of spontaneous peritonitis in rats undergoing chronic peritoneal dialysis.
Pawlaczyk K; Holmes CJ; Czekalski S; Breborowicz A; Lindholm B
Blood Purif; 2009; 28(3):200-8. PubMed ID: 19648739
[TBL] [Abstract][Full Text] [Related]
59. Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis.
Gillerot G; Devuyst O
Clin Nephrol; 2003 Jul; 60(1):1-6. PubMed ID: 12872851
[TBL] [Abstract][Full Text] [Related]
60. Effect of balance Solution on the Peritoneal Membrane in Automated Peritoneal Dialysis.
De Los Ríos T; Pérez-Martínez J; Portoles J; Lichodziejewska-Niemierko M; Rivera M; Nowicki M; Książek A; Tato AM; Bohnhorst C; Feriani M
Perit Dial Int; 2016 9-10; 36(5):569-72. PubMed ID: 27659931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
